EE05380B1 - FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid - Google Patents

FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid

Info

Publication number
EE05380B1
EE05380B1 EEP200400007A EEP200400007A EE05380B1 EE 05380 B1 EE05380 B1 EE 05380B1 EE P200400007 A EEP200400007 A EE P200400007A EE P200400007 A EEP200400007 A EE P200400007A EE 05380 B1 EE05380 B1 EE 05380B1
Authority
EE
Estonia
Prior art keywords
pharmaceutical
acidandcontaining
phenolethanolamine
preparation
crystalline form
Prior art date
Application number
EEP200400007A
Other languages
English (en)
Estonian (et)
Inventor
Antoine�Caron
Olivier�Monnier
Sabrina�Obert
J�rome�Roche
Isabelle�Ziri
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE200400007A publication Critical patent/EE200400007A/xx
Publication of EE05380B1 publication Critical patent/EE05380B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200400007A 2001-06-28 2002-06-27 FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid EE05380B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108562A FR2826651B1 (fr) 2001-06-28 2001-06-28 Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
PCT/FR2002/002235 WO2003002510A1 (fr) 2001-06-28 2002-06-27 Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Publications (2)

Publication Number Publication Date
EE200400007A EE200400007A (et) 2004-02-16
EE05380B1 true EE05380B1 (et) 2011-02-15

Family

ID=8864888

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200400007A EE05380B1 (et) 2001-06-28 2002-06-27 FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid

Country Status (30)

Country Link
US (1) US6992211B2 (xx)
EP (1) EP1404641B1 (xx)
JP (2) JP4171413B2 (xx)
KR (1) KR100869017B1 (xx)
CN (1) CN1269797C (xx)
AR (1) AR034648A1 (xx)
AT (1) ATE403642T1 (xx)
AU (1) AU2002333942B2 (xx)
BR (1) BR0210661A (xx)
CA (1) CA2450213C (xx)
CY (1) CY1110099T1 (xx)
CZ (1) CZ301450B6 (xx)
DE (1) DE60228088D1 (xx)
DK (1) DK1404641T3 (xx)
EE (1) EE05380B1 (xx)
ES (1) ES2307798T3 (xx)
FR (1) FR2826651B1 (xx)
HK (1) HK1063621A1 (xx)
HU (1) HUP0401229A3 (xx)
IL (2) IL159134A0 (xx)
MX (1) MXPA03011742A (xx)
NO (1) NO331169B1 (xx)
NZ (1) NZ530140A (xx)
PL (1) PL206680B1 (xx)
PT (1) PT1404641E (xx)
SI (1) SI1404641T1 (xx)
SK (1) SK287355B6 (xx)
TW (1) TWI286129B (xx)
WO (1) WO2003002510A1 (xx)
ZA (1) ZA200309512B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EP1623705A1 (en) * 2004-07-09 2006-02-08 Sanofi-Aventis Use of phenylethanolaminotetralines for preparing anxiolytic drugs
FR2890862B1 (fr) * 2005-09-19 2008-01-25 Sanofi Aventis Sa Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.
EP3397765B1 (en) 2015-12-30 2023-02-01 Bio-Rad Laboratories, Inc. Method for quantitating the frequency of wild-type and mutant fragments in a nucleic acid sample

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235103A (en) * 1987-08-12 1993-08-10 Sanofi Process for the preparation of phenylethanolaminotetralins
US5198586A (en) * 1987-08-12 1993-03-30 Sanofi Process for the preparation of phenylethanolaminotetralins
ATE116284T1 (de) * 1987-08-12 1995-01-15 Sanofi Sa Verfahren zur o-alkylierung von n- (hydroxy)aralkylphenylethanolamin.
US5202466A (en) 1988-06-14 1993-04-13 Sanofi 2-amino-7-hydroxytetraline ethers
FR2648042B1 (fr) * 1989-06-13 1994-06-10 Midy Spa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires
US5312961A (en) * 1989-02-14 1994-05-17 Elf Sanofi 2-amino-7-hydroxytetralin carboxylalkyl ethers
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Also Published As

Publication number Publication date
JP4171413B2 (ja) 2008-10-22
TWI286129B (en) 2007-09-01
CN1269797C (zh) 2006-08-16
PL368055A1 (en) 2005-03-21
EP1404641B1 (fr) 2008-08-06
MXPA03011742A (es) 2004-07-01
ATE403642T1 (de) 2008-08-15
AU2002333942B2 (en) 2008-02-28
IL159134A (en) 2009-07-20
CA2450213A1 (en) 2003-01-09
HUP0401229A3 (en) 2008-03-28
EE200400007A (et) 2004-02-16
EP1404641A1 (fr) 2004-04-07
CZ301450B6 (cs) 2010-03-03
IL159134A0 (en) 2004-05-12
US20040180953A1 (en) 2004-09-16
BR0210661A (pt) 2004-10-05
PL206680B1 (pl) 2010-09-30
JP2009029804A (ja) 2009-02-12
SK287355B6 (sk) 2010-08-09
US6992211B2 (en) 2006-01-31
JP2004530725A (ja) 2004-10-07
NO20035839L (no) 2004-03-01
PT1404641E (pt) 2008-09-22
FR2826651A1 (fr) 2003-01-03
KR20040017817A (ko) 2004-02-27
CA2450213C (en) 2011-02-15
KR100869017B1 (ko) 2008-11-17
DK1404641T3 (da) 2008-12-08
SI1404641T1 (sl) 2008-10-31
SK15932003A3 (sk) 2004-05-04
ES2307798T3 (es) 2008-12-01
AR034648A1 (es) 2004-03-03
CN1522241A (zh) 2004-08-18
CZ20033531A3 (en) 2004-04-14
DE60228088D1 (de) 2008-09-18
FR2826651B1 (fr) 2005-09-02
WO2003002510A1 (fr) 2003-01-09
NZ530140A (en) 2005-05-27
CY1110099T1 (el) 2015-01-14
ZA200309512B (en) 2004-12-08
HK1063621A1 (en) 2005-01-07
HUP0401229A2 (hu) 2004-10-28
JP4799592B2 (ja) 2011-10-26
NO331169B1 (no) 2011-10-24

Similar Documents

Publication Publication Date Title
NO20033556L (no) Farmasöytiske formuleringer
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
ATE296619T1 (de) Feste orale dosierungsform von simethicon
NO20031692D0 (no) Fremgangsmåte for fremstilling av pulverformuleringer
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
HUP0402338A3 (en) Spiro-hydantoin compounds, their use as anti-inflammatory agents, pharmaceutical compositions containing them and intermediates for preparing them
HUP0501186A2 (en) Pharmaceutical compositions comprising active vitamin d compounds
DE60206889D1 (de) Pharmazeutische formulierung enthaltend bicalutamid
NO20040125L (no) Enterale formuleringer
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
DK1414409T3 (da) Stabiliseret oral suspensionsformulering
EE200300589A (et) Ravimkoostised
DE60211183D1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
IS6021A (is) Lyfjasamsetningar sem innihalda sítalópram
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
EE05380B1 (et) FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid
EE200300548A (et) Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
NO20033073D0 (no) Farmasöytisk sammensetning inneholdende citalopram
NO20042074L (no) Makrolider inneholdende farmasoytiske sammensetninger

Legal Events

Date Code Title Description
HC1A Change of owner name
MM4A Lapsed by not paying the annual fees

Effective date: 20120627